☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

BNF 72

The 72nd Edition of the British National Formulary has recently been published. As previously noted, hard copies of the BNF will now only be distributed annually in the NHS.

Some of the significant content updates in this edition include:

  • New safety information about the risk of abnormal pregnancy outcomes with sodium valproate and valproic acid
  • Updated guidance for conditions including asthma, obesity, coeliac disease, irritable bowel syndrome and prostate cancer
  • New drug monographs including edoxaban, albiglutide, dulaglutide, dasabuvir, and vortioxetine
  • Updated pregnancy-prevention advice for patients taking mycophenolate mofetil
  • Updated guidance on the risk of hepatitis B reactivation with BCR-ABL tyrosine kinase inhibitors, and pomalidomide
  • Advice about the risk of ulceration with nicorandil treatment
  • NICE guidelines including the use of vedolizumab for treating moderately to severely active Crohn’s disease
  • New guidance on suspected or confirmed drug allergy
  • Evidence grading of BNF recommendations

The web version is updated monthly and can be accessed via NHS computers or via NICE Evidence Services. The printed version is also available for purchase.

Action: All clinicians should start using BNF 72 via electronic methods were possible. The web version can be used to access the latest information if necessary.

Share 'BNF 72' by emailShare 'BNF 72' on FacebookShare 'BNF 72' on TwitterShare 'BNF 72' on LinkedInShare 'BNF 72' on reddit


No Comments to “BNF 72”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.